Studies on PARP-1 expression in liver tissue as a factor in the development of hepatocellular carcinoma. The group has proven that inhibition of PARP-a (a protein that regulates different signalling pathways involved in hepatocarcinogenesis) is capable of controlling hepatocarcinome growth and prevents from tumor angiogenesis through the regulation of the genes involved in tumor progression.